Pavankumar N Petluru Selected Research

2,2'-dithiodiethanesulfonic acid (dimesna)

3/2015	Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787.
1/2015	Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787.
9/2010	BNP7787-mediated modulation of paclitaxel- and cisplatin-induced aberrant microtubule protein polymerization in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pavankumar N Petluru Research Topics

Disease

3	Neoplasms (Cancer) 03/2015 - 07/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2015 - 01/2015
2	Adenocarcinoma 01/2015 - 09/2010
1	Lung Neoplasms (Lung Cancer) 09/2010
1	Nausea 09/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2010
1	Anemia 09/2010
1	Vomiting 09/2010

Drug/Important Bio-Agent (IBA)

3	2,2'-dithiodiethanesulfonic acid (dimesna)IBA 03/2015 - 09/2010
1	Proteins (Proteins, Gene)FDA Link 03/2015
1	PlatinumIBA 09/2010
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2010
1	taxaneIBA 09/2010
1	Docetaxel (Taxotere)FDA Link 09/2010
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2010
1	Cisplatin (Platino)FDA LinkGeneric 09/2010
1	Investigational DrugsIBA 09/2010
1	Carboplatin (JM8)FDA LinkGeneric 09/2010
1	Pharmaceutical PreparationsIBA 07/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2015 - 09/2010
1	Combination Drug Therapy (Combination Chemotherapy) 09/2010
1	Therapeutics 07/2003